2022
Selfie Videos to Reduce Stigma and Increase Treatment Seeking Among Youths: Two Noninferiority Randomized Controlled Trials
Amsalem D, Jankowski SE, Pagdon S, Valeri L, Yang LH, Markowitz JC, Neria Y, Pescosolido BA, Dixon LB, Martin A. Selfie Videos to Reduce Stigma and Increase Treatment Seeking Among Youths: Two Noninferiority Randomized Controlled Trials. Psychiatric Services 2022, 74: 229-236. PMID: 36254455, DOI: 10.1176/appi.ps.20220168.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentFollow-Up StudiesHumansMental HealthPsychotic DisordersRandomized Controlled Trials as TopicSocial StigmaYoung AdultConceptsTreatment-seeking intentionsControl conditionBrief videoD effect sizesIntervention videoYoung adultsIllness-related stigmaMental health stigmaAdolescent depressionCohen's d effect sizesHealth stigmaStudy 2Study 1Treatment engagementThemes of recoveryAdolescentsEffect sizeShort videosRepeated-measures analysisStigmaIntentionSimilar efficacyAdultsVideoSocial media influencers
2005
Electrocardiographic Changes in Children and Adolescents Treated With Ziprasidone: A Prospective Study
BLAIR J, SCAHILL L, STATE M, MARTIN A. Electrocardiographic Changes in Children and Adolescents Treated With Ziprasidone: A Prospective Study. Journal Of The American Academy Of Child & Adolescent Psychiatry 2005, 44: 73-79. PMID: 15608546, DOI: 10.1097/01.chi.0000145372.61239.bb.Peer-Reviewed Original ResearchConceptsQTc intervalClose electrocardiographic monitoringMean QTc prolongationQTc-prolonging agentsOpen-label trialLonger QTc intervalsCurrent treatment standardsQRS complex widthZiprasidone dosePediatric outpatientsQTc prolongationElectrocardiographic changesElectrocardiographic monitoringProspective studyMean ageSafety profilePeak QTcHeart rateHigh dosesZiprasidoneTreatment standardsDoseDosesPreliminary findingsProlongation
2004
Is the Party Over? Cannabis and Juvenile Psychiatric Disorder: The Past 10 Years
REY JM, MARTIN A, KRABMAN P. Is the Party Over? Cannabis and Juvenile Psychiatric Disorder: The Past 10 Years. Journal Of The American Academy Of Child & Adolescent Psychiatry 2004, 43: 1194-1205. PMID: 15381886, DOI: 10.1097/01.chi.0000135623.12843.60.Peer-Reviewed Original ResearchConceptsJuvenile psychiatric disordersPsychiatric disordersOnset of schizophreniaRole of cannabisMental health effectsRate of useRegular marijuana usePsychotic illnessDepressive symptomsRegular cannabisMental disordersSuicidal behaviorPsychosocial functioningLiterature databasesSystematic searchHealth effectsLate increaseCannabisDisordersAdolescent dataBehavioral problemsRecent dataMarijuana useCannabis researchEvidence points
2002
Triglyceride, cholesterol and weight changes among risperidone-treated youths
Martin A, L'Ecuyer S. Triglyceride, cholesterol and weight changes among risperidone-treated youths. European Child & Adolescent Psychiatry 2002, 11: 129-133. PMID: 12369772, DOI: 10.1007/s00787-002-0255-5.Peer-Reviewed Original ResearchConceptsRisperidone-treated youthsMean ageWeight gainRetrospective chart reviewWeight changeRegular laboratory monitoringAtypical antipsychotic useSignificant weight gainSample mean ageChart reviewRisperidone doseAntipsychotic useSerum triglyceridesLaboratory monitoringTriglyceride levelsCholesterol levelsLipid dysregulationAdolescent inpatientsTriglyceridesPreliminary reportMeasures analysisSuch associationsCholesterolSignificant changesAverage length